V Muratov 1, J Lundahl, A K Ulfgren, K Elvin, I Fehrman, N Ahlborg, A Ost, N Hittel, A Saniabadi, R Löfberg, Int J Colorectal Dis . 2006 Sep;21(6):493-504.
Down-regulation of interfeferon-γ parallels clinical response to selective leukocyte apheresis in patients with inflammatory bowel disease:a 12-month follow-up study
Leukocyte apheresis is a novel and safe nonpharmacological adjunct therapy that may prove useful in steroid refractory or dependent patients when conventional drugs have failed. Down-regulation of IFN-gamma in mucosal biopsies and in peripheral leukocytes may be a predictive marker for sustained, long-term response.
Contact UsFor more informationContact Us